Danofloxacin

Danofloxacin
Danofloxacin
Systematic (IUPAC) name
1-Cyclopropyl-6-fluoro-7-[(1S,4S)-3-methyl-3,6-diazabicyclo[2.2.1]heptan-6-yl]-4-oxoquinoline-3-carboxylic acid
Clinical data
AHFS/Drugs.com International Drug Names
Pregnancy cat.  ?
Legal status  ?
Identifiers
CAS number 112398-08-0 YesY
ATCvet code QJ01MA92
PubChem CID 71335
UNII 24CU1YS91D N
ChEMBL CHEMBL157548 N
Chemical data
Formula C19H20FN3O3 
Mol. mass 357.37 g/mol
 N(what is this?)  (verify)

Danofloxacin is a fluoroquinolone antibiotic used in veterinary medicine.[1]

See also

  • Quinolone
  • Adverse effects of fluoroquinolones

References

  1. ^ Lees, P.; Shojaee Aliabadi, F. (Apr 2002). "Rational dosing of antimicrobial drugs: animals versus humans.". Int J Antimicrob Agents 19 (4): 269–84. PMID 11978498. 


v · d · eAntibacterials: nucleic acid inhibitors (J01E, J01M)
Antifolates
(inhibits
purine metabolism,
thereby inhibiting
DNA and RNA synthesis)
2,4-Diaminopyrimidine (Trimethoprim#, Brodimoprim, Tetroxoprim, Iclaprim†)
Sulfonamides
(DHPS inhibitor)
Other/ungrouped
Combinations
Topoisomerase
inhibitors/
quinolones/
(inhibits
DNA replication)
1st g.
2nd g.
3rd g.
4th g.
Vet.
Related (DG)
Anaerobic DNA
inhibitors
Nitro- imidazole derivatives
Nitrofuran derivatives
RNA synthesis
#WHO-EM. ‡Withdrawn from market. Clinical trials: †Phase III. §Never to phase III

M: BAC

bact (clas)

gr+f/gr+a(t)/gr-p(c)/gr-o

drug(J1p, w, n, m, vacc)


Stub icon This systemic antibacterial-related article is a stub. You can help Wikipedia by expanding it.